CIBERESPAÇO DE PESQUISA SOBRE CORONAVÍRUS: UMA REVISÃO INTEGRATIVA
SARS-COV-2 / COVID-19 RESEARCH REPOSITORY: AN INTEGRATIVE REVIEW
Palavras-chave:
Coronavírus, Síndrome Respiratória Aguda Grave, COVID-19Resumo
Identificar na literatura científica o que sendo discutido sobre Coronavírus, para a população e profissionais de saúde. Trata-se de uma revisão integrativa para desenvolvimento do repositório de pesquisa no site oficial do Governo do Estado do Ceará, Brasil. Foram utilizadas as bases de dados da área da saúde, com utilização de artigos na íntegra em inglês, português ou espanhol com recorte temporal de fevereiro a abril de 2020. Os artigos foram sistematizados e categorizados. Foram contemplados nos estudos a origem do vírus, doença, epidemiologia, sintomas, formas de transmissão, grupos de risco, terapia intensiva, medicamentos, manifestações clínicas, radiológicas, estratégias de cuidado e dificuldades. O repositório foi fundamental para subsidiar a tomada de decisão da gestão, profissionais da assistência e fortalecer a população uma informação clara e de fácil acesso para o autocuidado.
Descritores: Coronavírus; Síndrome Respiratória Aguda Grave; COVID-19.
ABSTRACT
Identify in the scientific literature what is being discussed about Coronavirus, for the population and health professionals. This is an integrative review for the development of the research repository on the official website of the State Government of Ceará, Brazil. The health area databases were used, with full articles in English, Portuguese or Spanish with a temporal cut from February to April 2020. The articles have been systematized and categorized. The studies included the origin of the virus, disease, epidemiology, symptoms, forms of transmission, risk groups, intensive care, drugs, clinical and radiological manifestations, care strategies and difficulties. The repository was fundamental to support management decision making, assistance professionals and strengthen the population with clear and easily accessible information for self-care.
Descriptors: Coronavirus; Severe Acute Respiratory Syndrome; COVID-19.
RESUMEN
Identificar en la literatura científica lo que se está discutiendo sobre el Coronavirus, para la población y los profesionales de la salud. Se trata de un examen integrador para el desarrollo del depósito de investigaciones en el sitio web oficial del Gobierno del Estado de Ceará (Brasil). Se utilizaron las bases de datos del área de la salud, con artículos completos en inglés, portugués o español con un corte temporal de febrero a abril de 2020. Los artículos han sido sistematizados y categorizados. Los estudios incluyeron el origen del virus, la enfermedad, la epidemiología, los síntomas, las formas de transmisión, los grupos de riesgo, los cuidados intensivos, las drogas, las manifestaciones clínicas y radiológicas, las estrategias de atención y las dificultades. El depósito era fundamental para apoyar la toma de decisiones de gestión, asistir a los profesionales y fortalecer a la población con información clara y de fácil acceso para el autocuidado.
Descriptores: Coronavirus; Síndrome Respiratorio Agudo Severo; COVID-19.
Downloads
Não há dados estatísticos.
Referências
1. HUANG C., et al. Características clínicas de pacientes infectados com o novo coronavírus de 2019 em Wuhan, China. Lanceta. 2020; 395: 497–506. doi: 10.1016 / S0140-6736 (20) 30183-5
2. LIU, J et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery. 2020 [acesso em 2020 Mar 14]; 6:16. doi: 10.1038 / s41421-020-0156-0. Disponível em: https://www.nature.com/articles/s41421- 020-0156-0
3. Zhu N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020; 382(8): 727–733. https://doi.org/10.1056/NEJ Moa2001017.
4. Organização Mundial de Saúde (OMS). Declaração sobre a segunda reunião do Comitê de Emergência do Regulamento Sanitário Internacional (2005) sobre o surto de novo coronavírus (COVID-19). Genebra: Organização Mundial de Saúde; 2020 [cited 2014 Mar 19]. Disponível em: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second meeting-of-the-international-health-regulations-(2005)-emergency-committee- sobre o surto de novo coronavírus (COVID-19).
5. ANVISA. Agência Nacional De Vigilância Sanitária. Nota técnica nº 04/2020 GVIMS/GGTES/ANVISA: Orientações para Serviços de Saúde: Medidas de Prevenção e Controle que Devem ser Adotadas Durante a Assistência aos Casos Suspeitos ou Confirmados de Infecção pelo Novo Coronavírus (2019- ncov). Agência Nacional De Vigilância Sanitária (ANVISA). 30 de março de 2020. http://portal.anvisa.gov.br/servicos/publicacoes.
6. Brasil. Ministério da Saúde. Brasil registra 438.23 casos confirmados de coronavírus e 26.764 mortes. Brasília. Site Coronavírus Brasil. 2020. Disponível em: https://covid.saude.gov.br/. Acesso em 29 de maio de 2020.
7. Sesa. Secretaria da Saúde do Ceará. Indicadores de Saúde sobre Covis-19 no Integra SUS. Fortaleza-CE. Secretaria da Saúde do Ceará (Sesa). 2020. https://indicadores.integrasus.saude.ce.gov.br/indicadores/indicadores-coronavirus/coronavirus-ceara. Acesso em 29 de maio de 2020.
8. Agência Nacional De Vigilância Sanitária. Nota técnica nº 04/2020 GVIMS/GGTES/ANVISA: Orientações para Serviços de Saúde: Medidas de Prevenção e Controle que Devem ser Adotadas Durante a Assistência aos Casos Suspeitos ou Confirmados de Infecção pelo Novo Coronavírus (2019- ncov), 30 jan. 2020. Disponível em: http://portal.anvisa.gov.br/servicos/publicacoes. Acesso em: 22 mar. 2020.
9. Lévy, P. (1999). Cibercultura. (C. I. da Costa, Trad.). São Paulo: Ed. 34. (Trabalho original publicado em 1997).
10. Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010; 8(1): 102-6.
11. Mendes Karina Dal Sasso, Silveira Renata Cristina de Campos Pereira, Galvão Cristina Maria. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto contexto – enferm. [Internet]. 2008 Dec [cited 2020 Abr 8];17(4):758-764. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072008000400018
12. Cooke A, Smith D, Booth A. Beyond PICO: The SPIDER Tool for qualitative evidence synthesis. Qual Health Res 2012; 22(10):1435-1443.
13. Minayo MCS. Técnicas de análise domaterial qualitativo. In: Minayo MCS. O Desafio do conhecimento: pesquisa qualitativa em saúde. São Paulo: Hucitec; 303-60, 2010.
14. KHAN, Suliman; SIDDIQUE, Rabeea; SHEREEN, Muhammad Adnan; et. al. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Journal of Clinical Microbiology, 2020; 58: e00187-20. https://doi.org/10.1128/JCM.00187-20.
15. SUN, Pengfei; LU, Xiaosheng; XU, Chao; et. al. Understanding of COVID‐19 based on current evidence. Journal of Medical Virology, 2020; 92:548–551. DOI: https://doi.org/10.1002/jmv.2572.
16. HAN, Qingmei; LIN, Qingqing; JIN, Shenhe; et. al. Coronavirus 2019-nCoV: A brief perspective from the front line. Journal of Infection, 2020; 80:373–377. DOI: https://doi.org/10.1016/j.jinf.2020.02.010.
17. WILDER-SMITH, Annelies; CHIEW, Calvin J; LEE, Vernon J. Can we contain the COVID-19 outbreak with the same measures as for SARS? The Lancet Infect, 2020; 20: e102–07. DOI: https://doi.org/10.1016/ S1473-3099(20)30129-8
18. ASHOUR, Hossam M; ELKHATIB, Walid F; RAHMAN, Masudur. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Journal. Pathogens, 2020; 9:186. DOI: 10.3390/pathogens9030186.
19. SIORDIA JR; Juan A. Epidemiology and clinical features of COVID-19: A review of current Literature. Journal of Clinical Virology, 2020; 127:104357. DOI: https://doi.org/10.1016/j.jcv.2020.104357
20. ROTHAN, Hussin A; BYRAREDDY, Siddappa N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 2020; 109:102433. DOI: https://doi.org/10.1016/j.jaut.2020.102433
21. JOOB, Beuy; WIWANITKIT ,Viroj. COVID-19 can present with a rash and be mistaken for dengue. Journal Am. Acad. Dermatology, 2020; 82, 5: e177. DOI: 10.1016 / j.jaad.2020.03.036.
22. LI, Mingzhi; LEI, Pinggui; ZENG, Bingliang; et. al. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease. Acad Radiol, 2020; 27(5):603-608. DOI: 10.1016/j.acra.2020.03.003.
23. ZHOU, Fei; YU, Ting; DU, Ronghui; et. al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020; 395: 1054–62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3.
24. KISSLER, Stephen M; TEDIJANTO, Christine; GOLSTEIN, Edward; et. al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science, 2020; 368:6493; 860-868. DOI: 10.1126/science.abb5793originally.
25. RODRIGUEZ-MORALES, Alfonso J; GALLEGO, Viviana; ESCALERA-ANTEZANA, Juan Pablo; et. al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Elsevier, 2020; 1477-8939. DOI: https://doi.org/10.1016/j.tmaid.2020.10161
26. PENG, Xian; XU, Xin; LI, Yuqing. Transmission routes of 2019-nCoV and controls in dental practice. International Journal of Oral Science, 2020; 12:9. DOI: https://doi.org/10.1038/s41368-020-0075-9
27. FANG L, KARAKIULAKIS G, ROTH M. Os pacientes com hipertensão e diabetes mellitus estão em maior risco de infecção por COVID-19? The Lancet. 2020; 8(4):1. Doi: https://doi.org/10.1016/ S2213-2600(20)30116-8.
28. LU, Qi; SHI, Yuan. Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know. Journal Medical Virology, 2020; 92:564–567. DOI: 10.1002/jmv.25740
29. LI, Geng; FAN, Yaohua; LAI, Yanni. Coronavirus infections and immune responses. Journal Medical Virology, 2020; 92:424–432. DOI: 10.1002/jmv.25685
30. WU, Chaomin; CHEN, Xiaoyan; CAI, Yanping; et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 2020. DOI: 10.1001/jamainternmed.2020.0994
31. MADJID, Mohammad; SAFAVI-NAEINI, Payam; SOLOMON, Scott D; et. al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology, 2020. DOI:10.1001/jamacardio.2020.1286
32. SILVA AAM. Sobre a possibilidade de interrupção da epidemia pelo coronavírus (COVID-19) com base nas melhores evidências científicas disponíveis. Rev. bras. Epidemiol. Vol.23. Rio de Janeiro. 2020. Epub Mar 16, 2020. https://doi.org/10.1590/1980-549720200021
33. SIDDIQI, Hasan K; MEHRA, Mandeep R. Mehra. COVID-19 illness in native and immunosuppressed states: A clinical−therapeutic staging proposal. The Journal of Heart and Lung Transplantation, 2020; v.39, 5:405-407. DOI: https://doi.org/10.1016/j.healun.2020.03.012
34. ZHOU, Min; ZHANG, Xinxin; QU, Jieming. Coronavirus disease 2019 (COVID-19): a clinical update. Frontiers of Medicine, 2020; 14(2:126–135. DOI: https://doi.org/10.1007/s11684-020-0767-8
35. ALHAZZANI, Waleed; MOLLER, Morten Hylander; ARABI, Yaseen M; et. al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine, 2020; 48(6):p e440-e469. DOI: 10.1097 /CCM.0000000000004363
36. CANELLI, Robert; CONNOR, Christopher W; GONZALEZ, Mauricio; et. al. Barrier Enclosure during Endotracheal Intubation. The New England Journal of Medicine, 2020; 382; DOI: 10.1056/NEJMc2007589
37. MARINI, John J; GATTINONI, Luciano. Tratamento do desconforto respiratório do COVID-19. JAMA, 2020. DOI: 10.1001/jama.2020.682
38. GAUTRET, Philippe; LAGIER, Jean Christophe; PAROLA, Philippe; et. al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 2020; 105949: S0924-8579. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105949
39. BARBOSA, Joshua; KAITIS, Daniel; FREEDMAN, Ryan; et. al. Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study. The New England Journal of Medicine, 2020; 20:08882.
40. MEHRA, Mandeep R; DESAI, Sapan S; RUSCHITZKA, Frank; PATEL, Amit N. P. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet On Line, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)31174-0
41. MARTINEZ M. A. 2020. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother, 2020; 64:e00399-20. DOI: https://doi.org/10.1128/AAC.00399-20.
42. YUAN, Mingli; YIN, Wen; TAO, Zhaowu. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. Journal Plos One, 2020; 15(3):e0230548. DOI: https://doi.org/10.1371/journal.pone.0230548
43. AI, Tao; YANG, Zhenlu; HOU, Hongyan. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, 2020. DOI: https://doi.org/10.1148/radiol.2020200642
44. ARAUJO-FILHO, José de Arimateia Batista; SAWAMURA, Marcio Valente Yamada; COSTA, André Nathan; et. al. Pneumonia por COVID-19: qual o papel da imagem no diagnóstico? Jornal Brasileiro de Pneumologia, 2020; 46(2):e20200114. DOI: https://dx.doi.org/10.36416/1806-3756/e20200114
45. PAN, Feng; YE, Tianhe; SUN, Peng; et. al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology, 2020; 295:715–721. DOI: https://doi.org/10.1148/radiol.2020200370
46. HAN, Rui; HUANG, Lu; JIANG, Hong; et. al. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. American Journal of Roentgenology, 2020; 215:1-6. DOI: doi.org/10.2214/AJR.20.22961
47. LIU, Kai-Cai; XU, Ping; LV, Wei-Fu; et. al. CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity. European Journal of Radiology, 2020; 126. DOI: https://doi.org/10.1016/j.ejrad.2020.108941
48. LI, Mingzhi; LEI, Pinggui; ZENG, Bingliang; et. al. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease. Acad Radiol, 2020; 27(5):603-608. DOI: 10.1016/j.acra.2020.03.003.
49. GUAN, Chun Shuang; LV, Zhi Bin; YAN, Shuo. Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT. Academic Radiology, 2020; 27(5). DOI: https://doi.org/10.1016/j.acra.2020.03.002
50. YANG, Yongshi; PENG, Fujun; WANG, Runsheng; et. al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity, 2020; 109:102434. DOI: https://doi.org/10.1016/j.jaut.2020.102434
51. SOHRABI, Catrin; ALSAFI, Zaid; Niamh, O’NEILL; et. al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 2020; 76:71–76. DOI: https://doi.org/10.1016/j.ijsu.2020.02.034
52. CRODA, Julio; OLIVEIRA, Wanderson Kleber de; FRUTUOSO, Rodrigo Lins. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases. Revista da Sociedade Brasileira de Medicina Tropical, 2020; 53:e20200167. DOI: 10.1590/0037-8682-0167-2020
53. COWLING, Benjamin J; ALI, Sheikh Taslim; NG, Tiffany W. Y; et. al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health, 2020; 5:e279–88. DOI: https://doi.org/10.1016/S2468-2667(20)30090-6
54. LIMA, Danilo Lopes Ferreira; DIAS, Aldo Angelim; RABELO, Renata Sabóia; CRUZ, Igor Demes da; COSTA, Samuel Carvalho; NIGRI, Flávia Maria Noronha; NERI, Jiovanne Rabelo. COVID-19 no estado do Ceará, Brasil: comportamentos e crenças na chegada da pandemia. Ciência & Saúde Coletiva, 2020; 25; 5:1575-1586. DOI: 10.1590/1413-81232020255.07192020
2. LIU, J et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery. 2020 [acesso em 2020 Mar 14]; 6:16. doi: 10.1038 / s41421-020-0156-0. Disponível em: https://www.nature.com/articles/s41421- 020-0156-0
3. Zhu N, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine. 2020; 382(8): 727–733. https://doi.org/10.1056/NEJ Moa2001017.
4. Organização Mundial de Saúde (OMS). Declaração sobre a segunda reunião do Comitê de Emergência do Regulamento Sanitário Internacional (2005) sobre o surto de novo coronavírus (COVID-19). Genebra: Organização Mundial de Saúde; 2020 [cited 2014 Mar 19]. Disponível em: https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second meeting-of-the-international-health-regulations-(2005)-emergency-committee- sobre o surto de novo coronavírus (COVID-19).
5. ANVISA. Agência Nacional De Vigilância Sanitária. Nota técnica nº 04/2020 GVIMS/GGTES/ANVISA: Orientações para Serviços de Saúde: Medidas de Prevenção e Controle que Devem ser Adotadas Durante a Assistência aos Casos Suspeitos ou Confirmados de Infecção pelo Novo Coronavírus (2019- ncov). Agência Nacional De Vigilância Sanitária (ANVISA). 30 de março de 2020. http://portal.anvisa.gov.br/servicos/publicacoes.
6. Brasil. Ministério da Saúde. Brasil registra 438.23 casos confirmados de coronavírus e 26.764 mortes. Brasília. Site Coronavírus Brasil. 2020. Disponível em: https://covid.saude.gov.br/. Acesso em 29 de maio de 2020.
7. Sesa. Secretaria da Saúde do Ceará. Indicadores de Saúde sobre Covis-19 no Integra SUS. Fortaleza-CE. Secretaria da Saúde do Ceará (Sesa). 2020. https://indicadores.integrasus.saude.ce.gov.br/indicadores/indicadores-coronavirus/coronavirus-ceara. Acesso em 29 de maio de 2020.
8. Agência Nacional De Vigilância Sanitária. Nota técnica nº 04/2020 GVIMS/GGTES/ANVISA: Orientações para Serviços de Saúde: Medidas de Prevenção e Controle que Devem ser Adotadas Durante a Assistência aos Casos Suspeitos ou Confirmados de Infecção pelo Novo Coronavírus (2019- ncov), 30 jan. 2020. Disponível em: http://portal.anvisa.gov.br/servicos/publicacoes. Acesso em: 22 mar. 2020.
9. Lévy, P. (1999). Cibercultura. (C. I. da Costa, Trad.). São Paulo: Ed. 34. (Trabalho original publicado em 1997).
10. Souza MT, Silva MD, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein. 2010; 8(1): 102-6.
11. Mendes Karina Dal Sasso, Silveira Renata Cristina de Campos Pereira, Galvão Cristina Maria. Revisão integrativa: método de pesquisa para a incorporação de evidências na saúde e na enfermagem. Texto contexto – enferm. [Internet]. 2008 Dec [cited 2020 Abr 8];17(4):758-764. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-07072008000400018
12. Cooke A, Smith D, Booth A. Beyond PICO: The SPIDER Tool for qualitative evidence synthesis. Qual Health Res 2012; 22(10):1435-1443.
13. Minayo MCS. Técnicas de análise domaterial qualitativo. In: Minayo MCS. O Desafio do conhecimento: pesquisa qualitativa em saúde. São Paulo: Hucitec; 303-60, 2010.
14. KHAN, Suliman; SIDDIQUE, Rabeea; SHEREEN, Muhammad Adnan; et. al. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Journal of Clinical Microbiology, 2020; 58: e00187-20. https://doi.org/10.1128/JCM.00187-20.
15. SUN, Pengfei; LU, Xiaosheng; XU, Chao; et. al. Understanding of COVID‐19 based on current evidence. Journal of Medical Virology, 2020; 92:548–551. DOI: https://doi.org/10.1002/jmv.2572.
16. HAN, Qingmei; LIN, Qingqing; JIN, Shenhe; et. al. Coronavirus 2019-nCoV: A brief perspective from the front line. Journal of Infection, 2020; 80:373–377. DOI: https://doi.org/10.1016/j.jinf.2020.02.010.
17. WILDER-SMITH, Annelies; CHIEW, Calvin J; LEE, Vernon J. Can we contain the COVID-19 outbreak with the same measures as for SARS? The Lancet Infect, 2020; 20: e102–07. DOI: https://doi.org/10.1016/ S1473-3099(20)30129-8
18. ASHOUR, Hossam M; ELKHATIB, Walid F; RAHMAN, Masudur. Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks. Journal. Pathogens, 2020; 9:186. DOI: 10.3390/pathogens9030186.
19. SIORDIA JR; Juan A. Epidemiology and clinical features of COVID-19: A review of current Literature. Journal of Clinical Virology, 2020; 127:104357. DOI: https://doi.org/10.1016/j.jcv.2020.104357
20. ROTHAN, Hussin A; BYRAREDDY, Siddappa N. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 2020; 109:102433. DOI: https://doi.org/10.1016/j.jaut.2020.102433
21. JOOB, Beuy; WIWANITKIT ,Viroj. COVID-19 can present with a rash and be mistaken for dengue. Journal Am. Acad. Dermatology, 2020; 82, 5: e177. DOI: 10.1016 / j.jaad.2020.03.036.
22. LI, Mingzhi; LEI, Pinggui; ZENG, Bingliang; et. al. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease. Acad Radiol, 2020; 27(5):603-608. DOI: 10.1016/j.acra.2020.03.003.
23. ZHOU, Fei; YU, Ting; DU, Ronghui; et. al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020; 395: 1054–62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-3.
24. KISSLER, Stephen M; TEDIJANTO, Christine; GOLSTEIN, Edward; et. al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science, 2020; 368:6493; 860-868. DOI: 10.1126/science.abb5793originally.
25. RODRIGUEZ-MORALES, Alfonso J; GALLEGO, Viviana; ESCALERA-ANTEZANA, Juan Pablo; et. al. COVID-19 in Latin America: The implications of the first confirmed case in Brazil. Elsevier, 2020; 1477-8939. DOI: https://doi.org/10.1016/j.tmaid.2020.10161
26. PENG, Xian; XU, Xin; LI, Yuqing. Transmission routes of 2019-nCoV and controls in dental practice. International Journal of Oral Science, 2020; 12:9. DOI: https://doi.org/10.1038/s41368-020-0075-9
27. FANG L, KARAKIULAKIS G, ROTH M. Os pacientes com hipertensão e diabetes mellitus estão em maior risco de infecção por COVID-19? The Lancet. 2020; 8(4):1. Doi: https://doi.org/10.1016/ S2213-2600(20)30116-8.
28. LU, Qi; SHI, Yuan. Coronavirus disease (COVID‐19) and neonate: What neonatologist need to know. Journal Medical Virology, 2020; 92:564–567. DOI: 10.1002/jmv.25740
29. LI, Geng; FAN, Yaohua; LAI, Yanni. Coronavirus infections and immune responses. Journal Medical Virology, 2020; 92:424–432. DOI: 10.1002/jmv.25685
30. WU, Chaomin; CHEN, Xiaoyan; CAI, Yanping; et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 2020. DOI: 10.1001/jamainternmed.2020.0994
31. MADJID, Mohammad; SAFAVI-NAEINI, Payam; SOLOMON, Scott D; et. al. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiology, 2020. DOI:10.1001/jamacardio.2020.1286
32. SILVA AAM. Sobre a possibilidade de interrupção da epidemia pelo coronavírus (COVID-19) com base nas melhores evidências científicas disponíveis. Rev. bras. Epidemiol. Vol.23. Rio de Janeiro. 2020. Epub Mar 16, 2020. https://doi.org/10.1590/1980-549720200021
33. SIDDIQI, Hasan K; MEHRA, Mandeep R. Mehra. COVID-19 illness in native and immunosuppressed states: A clinical−therapeutic staging proposal. The Journal of Heart and Lung Transplantation, 2020; v.39, 5:405-407. DOI: https://doi.org/10.1016/j.healun.2020.03.012
34. ZHOU, Min; ZHANG, Xinxin; QU, Jieming. Coronavirus disease 2019 (COVID-19): a clinical update. Frontiers of Medicine, 2020; 14(2:126–135. DOI: https://doi.org/10.1007/s11684-020-0767-8
35. ALHAZZANI, Waleed; MOLLER, Morten Hylander; ARABI, Yaseen M; et. al. Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Medicine, 2020; 48(6):p e440-e469. DOI: 10.1097 /CCM.0000000000004363
36. CANELLI, Robert; CONNOR, Christopher W; GONZALEZ, Mauricio; et. al. Barrier Enclosure during Endotracheal Intubation. The New England Journal of Medicine, 2020; 382; DOI: 10.1056/NEJMc2007589
37. MARINI, John J; GATTINONI, Luciano. Tratamento do desconforto respiratório do COVID-19. JAMA, 2020. DOI: 10.1001/jama.2020.682
38. GAUTRET, Philippe; LAGIER, Jean Christophe; PAROLA, Philippe; et. al. Hydroxychloroquine and Azithromycin as a treatment of COVID-19: preliminary results of an open-label non-randomized clinical trial. International Journal of Antimicrobial Agents, 2020; 105949: S0924-8579. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105949
39. BARBOSA, Joshua; KAITIS, Daniel; FREEDMAN, Ryan; et. al. Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study. The New England Journal of Medicine, 2020; 20:08882.
40. MEHRA, Mandeep R; DESAI, Sapan S; RUSCHITZKA, Frank; PATEL, Amit N. P. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. The Lancet On Line, 2020. DOI: https://doi.org/10.1016/S0140-6736(20)31174-0
41. MARTINEZ M. A. 2020. Compounds with therapeutic potential against novel respiratory 2019 coronavirus. Antimicrob Agents Chemother, 2020; 64:e00399-20. DOI: https://doi.org/10.1128/AAC.00399-20.
42. YUAN, Mingli; YIN, Wen; TAO, Zhaowu. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China. Journal Plos One, 2020; 15(3):e0230548. DOI: https://doi.org/10.1371/journal.pone.0230548
43. AI, Tao; YANG, Zhenlu; HOU, Hongyan. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, 2020. DOI: https://doi.org/10.1148/radiol.2020200642
44. ARAUJO-FILHO, José de Arimateia Batista; SAWAMURA, Marcio Valente Yamada; COSTA, André Nathan; et. al. Pneumonia por COVID-19: qual o papel da imagem no diagnóstico? Jornal Brasileiro de Pneumologia, 2020; 46(2):e20200114. DOI: https://dx.doi.org/10.36416/1806-3756/e20200114
45. PAN, Feng; YE, Tianhe; SUN, Peng; et. al. Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19). Radiology, 2020; 295:715–721. DOI: https://doi.org/10.1148/radiol.2020200370
46. HAN, Rui; HUANG, Lu; JIANG, Hong; et. al. Early Clinical and CT Manifestations of Coronavirus Disease 2019 (COVID-19) Pneumonia. American Journal of Roentgenology, 2020; 215:1-6. DOI: doi.org/10.2214/AJR.20.22961
47. LIU, Kai-Cai; XU, Ping; LV, Wei-Fu; et. al. CT manifestations of coronavirus disease-2019: A retrospective analysis of 73 cases by disease severity. European Journal of Radiology, 2020; 126. DOI: https://doi.org/10.1016/j.ejrad.2020.108941
48. LI, Mingzhi; LEI, Pinggui; ZENG, Bingliang; et. al. Coronavirus Disease (COVID-19): Spectrum of CT Findings and Temporal Progression of the Disease. Acad Radiol, 2020; 27(5):603-608. DOI: 10.1016/j.acra.2020.03.003.
49. GUAN, Chun Shuang; LV, Zhi Bin; YAN, Shuo. Imaging Features of Coronavirus disease 2019 (COVID-19): Evaluation on Thin-Section CT. Academic Radiology, 2020; 27(5). DOI: https://doi.org/10.1016/j.acra.2020.03.002
50. YANG, Yongshi; PENG, Fujun; WANG, Runsheng; et. al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. Journal of Autoimmunity, 2020; 109:102434. DOI: https://doi.org/10.1016/j.jaut.2020.102434
51. SOHRABI, Catrin; ALSAFI, Zaid; Niamh, O’NEILL; et. al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 2020; 76:71–76. DOI: https://doi.org/10.1016/j.ijsu.2020.02.034
52. CRODA, Julio; OLIVEIRA, Wanderson Kleber de; FRUTUOSO, Rodrigo Lins. COVID-19 in Brazil: advantages of a socialized unified health system and preparation to contain cases. Revista da Sociedade Brasileira de Medicina Tropical, 2020; 53:e20200167. DOI: 10.1590/0037-8682-0167-2020
53. COWLING, Benjamin J; ALI, Sheikh Taslim; NG, Tiffany W. Y; et. al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health, 2020; 5:e279–88. DOI: https://doi.org/10.1016/S2468-2667(20)30090-6
54. LIMA, Danilo Lopes Ferreira; DIAS, Aldo Angelim; RABELO, Renata Sabóia; CRUZ, Igor Demes da; COSTA, Samuel Carvalho; NIGRI, Flávia Maria Noronha; NERI, Jiovanne Rabelo. COVID-19 no estado do Ceará, Brasil: comportamentos e crenças na chegada da pandemia. Ciência & Saúde Coletiva, 2020; 25; 5:1575-1586. DOI: 10.1590/1413-81232020255.07192020
Downloads
Publicado
30-12-2020
Como Citar
1.
Araújo de Carvalho J, Paiva de Abreu LD, Brito de Matos F, Franco Moreira FJ. CIBERESPAÇO DE PESQUISA SOBRE CORONAVÍRUS: UMA REVISÃO INTEGRATIVA : SARS-COV-2 / COVID-19 RESEARCH REPOSITORY: AN INTEGRATIVE REVIEW . Cadernos ESP [Internet]. 30º de dezembro de 2020 [citado 21º de dezembro de 2024];14(2):24-36. Disponível em: https://cadernos.esp.ce.gov.br/index.php/cadernos/article/view/503
Edição
Seção
Artigos de Revisão
Licença
Copyright (c) 2020 Cadernos ESP
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
